Current systemic treatment options and new developments in palliative first-line treatment of head and neck squamous cell carcinoma

被引：1
作者：
Kocher, Florian [1 ]
Seeber, Andreas [1 ]
机构：
[1] Med Univ Innsbruck, Comprehens Canc Ctr Innsbruck, Dept Internal Med Hematol & Oncol 5, Anichstr 35, A-6020 Innsbruck, Austria
来源：
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY | 2023年 / 16卷 / 03期
关键词：
Head and neck squamous cell carcinoma (HNSCC); Palliative first-line tratment; Recent trials; Treatment algorithm; OPEN-LABEL; PLUS PACLITAXEL; METASTATIC HEAD; PEMBROLIZUMAB; CETUXIMAB; CHEMOTHERAPY; RECURRENT; FLUOROURACIL; KEYNOTE-048; MULTICENTER;
D O I：
10.1007/s12254-023-00901-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This short review gives an overview of current treatment concepts, recently published trials, and novel developments in relapsed or metastatic head and neck squamous cell carcinoma (HNSCC) not amendable for local curative treatment. Trials with potential future clinical implications and relevant updates of landmark trials are provided as well.
引用
收藏
页码：176 / 179
页数：4
相关论文
共 50 条
  • [31] A comparison of weekly paclitaxel and cetuximab with the EXTREME regimen in the treatment of recurrent/metastatic squamous cell head and neck carcinoma
    Nakano, Kenji
    Marshall, Shoko
    Taira, Shinichiro
    Sato, Yukiko
    Tomomatsu, Junichi
    Sasaki, Toru
    Shimbashi, Wataru
    Fukushima, Hirofumi
    Yonekawa, Hiroyuki
    Mitani, Hiroki
    Kawabata, Kazuyoshi
    Takahashi, Shunji
    ORAL ONCOLOGY, 2017, 73 : 21 - 26
  • [32] Gefitinib, Methotrexate and Methotrexate plus 5-Fluorouracil as palliative treatment in recurrent head and neck squamous cell carcinoma
    Kushwaha, Vandana Singh
    Gupta, Seema
    Husain, Nuzhat
    Khan, Huma
    Negi, M. P. S.
    Jamal, Naseem
    Ghatak, Ashim
    CANCER BIOLOGY & THERAPY, 2015, 16 (02) : 346 - 351
  • [33] Exceptional Response to PD-1 Blockade as First-Line Therapy in Head and Neck Squamous Cell Carcinoma
    Kumai, Takumi
    Komatsuda, Hiroki
    Minami, Yoshinori
    Harabuchi, Yasuaki
    ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY, 2020, 82 (06): : 343 - 350
  • [34] Treatment Strategy for Distant Synchronous Metastatic Head and Neck Squamous Cell Carcinoma
    Tang, Eliane
    Lahmi, Lucien
    Meillan, Nicolas
    Pietta, Gianandrea
    Albert, Sebastien
    Maingon, Philippe
    CURRENT ONCOLOGY REPORTS, 2019, 21 (11)
  • [35] Characterization of Molecular Subtypes in Head and Neck Squamous Cell Carcinoma With Distinct Prognosis and Treatment Responsiveness
    Zhang, Pei
    Li, Shue
    Zhang, Tingting
    Cui, Fengzhen
    Shi, Ji-Hua
    Zhao, Faming
    Sheng, Xia
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [36] Treatment Options for Metastatic Urothelial Carcinoma After First-Line Chemotherapy
    Tassinari, Elisa
    Mollica, Veronica
    Nuvola, Giacomo
    Marchetti, Andrea
    Rosellini, Matteo
    Massari, Francesco
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 1945 - 1960
  • [37] Current Progress and Future Directions of Immunotherapy in Head and Neck Squamous Cell Carcinoma A Narrative Review
    Sim, Edward S.
    Nguyen, Hoang C. B.
    Hanna, Glenn J.
    Uppaluri, Ravindra
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2025,
  • [38] A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Bossi, P.
    Miceli, R.
    Locati, L. D.
    Ferrari, D.
    Vecchio, S.
    Moretti, G.
    Denaro, N.
    Caponigro, F.
    Airoldi, M.
    Moro, C.
    Vaccher, E.
    Sponghini, A.
    Caldara, A.
    Rinaldi, G.
    Ferrau, F.
    Nole, F.
    Lo Vullo, S.
    Tettamanzi, F.
    Hollander, L.
    Licitra, L.
    ANNALS OF ONCOLOGY, 2017, 28 (11) : 2820 - 2826
  • [39] Optimizing Treatment for Head and Neck Cancers: Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
    Haddad, Robert, I
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (07): : 982 - 984
  • [40] Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck Cancer
    Wagner, Sandro. M.
    Magnes, Teresa
    Melchardt, Thomas
    Kiem, Dominik
    Weiss, Lukas
    Neureiter, Daniel
    Wagner, Christina
    Aretin, Marie-Bernadette
    Nemec, Stefan
    Gamerith, Gabriele
    Pall, Georg
    Greil, Richard
    Fuereder, Thorsten
    ANTICANCER RESEARCH, 2023, 43 (03) : 1273 - 1282
12345